Sepideh Amin-Hanjani, MD
-
Specialty: Neurological Surgery
View Expertise -
Primary Location: 11100 Euclid Ave (0 mi.)
Other Locations - Languages Spoken: English
Office Locations
UH Cleveland Medical Center Bolwell (0 mi.)
11100 Euclid Ave
Bolwell 5th Floor
Cleveland, OH 44106
216-844-3192
UH Ahuja Risman Pavilion (5 mi.)
1000 Auburn Dr
Ste 200
Beachwood, OH 44122
216-844-3192
Biography: Sepideh Amin-Hanjani, MD
Expertise
Titles
- Director, Cerebrovascular and Skull Base Surgery, University Hospitals
- Vice Chair, Department of Neurological Surgery, UH Cleveland Medical Center
- Professor of Neurological Surgery, CWRU School of Medicine
- Warren R. Selman, MD, Chair in Neurosurgery, University Hospitals
Certifications & Memberships
- Neurological Surgery - American Board of Neurological Surgery
Education
Fellowship | Cerebrovascular/Skull Base Surgery
Cerebrovascular/Skull Base Surgery - Barrow Neurological Institute (2004 - 2005)
Residency | Neurological Surgery
Neurological Surgery - Massachusetts General Hospital (1995 - 2000)
Internship | General Surgery
General Surgery - Massachusetts General Hospital (1994 - 1995)
Medical Education
Harvard Medical School (1994)
Undergraduate
University Of Massachusetts (1990)
About
Sepideh Amin-Hanjani, MD, is a fellowship-trained, board-certified neurosurgeon and Director of Cerebrovascular and Skull Base Surgery at University Hospitals, where she also serves as Vice Chair of Neurological Surgery. Dr. Amin-Hanjani sees patients at University Hospitals Cleveland Medical Center and University Hospitals Ahuja Medical Center.
Dr. Amin-Hanjani specializes in cerebrovascular surgery for conditions such as aneurysms, vascular malformations, carotid disease and moyamoya. She also specializes in skull base surgery, an area in which she focuses on treating pituitary tumors, acoustic neuromas and certain other conditions.
Dr. Amin-Hanjani received her medical degree at Harvard Medical School and completed Neurosurgery residency training at the Massachusetts General Hospital in Boston, Massachusetts followed by a Cerebrovascular and Skull Base fellowship at the Barrow Neurological Institute in Phoenix, Arizona. She assumed a faculty position in the Department of Neurosurgery at the University of Illinois at Chicago (UIC) in 2003, where she subsequently became tenured Professor and served as Co-Director of Neurovascular Surgery until joining University Hospitals in 2022. She has been listed consistently in Best Doctors and Castle Connolly Top Doctors lists. She is also a recipient of the UIC Departmental Faculty of the Year award for Clinical Service.
Dr. Amin-Hanjani has long-standing research interests in the area of cerebrovascular blood flow and stroke, a specialty for which she has received research funding from NIH. She is actively involved with stroke research and has authored over 200 scientific publications and 30 textbook chapters on the subject. Dr Amin-Hanjani has presented at numerous national and international scientific conferences on topics such as surgical management of hemorrhagic and ischemic stroke.
Dr. Amin-Hanjani is an elected member of the Society of Neurological Surgeons, American Academy of Neurological Surgeons and the Society of University Surgeons. She has held leadership positions in major national Neurosurgery organizations, serving as a former member of the Executive Committee of the Congress of Neurological Surgeons (CNS) and as the current Treasurer of the American Association of Neurological Surgeons (AANS). Dr Amin-Hanjani is a past Chair of the AANS/CNS Joint Cerebrovascular Section and current Chair of the American Heart Association Stroke Council. She has long been an advocate for patients and serves as the Medical Advisory Board Regional Co-director for the Brain Aneurysm Foundation.
Featured Videos
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Sepideh Amin-Hanjani did not disclose any Outside Relationships with Industry.